ADMA Biologics Ownership | Who Owns ADMA Biologics?


OverviewForecastRevenueFinancialsChartTranscripts

ADMA Biologics Ownership Summary


ADMA Biologics is owned by 79.01% institutional investors, 2.55% insiders, and 18.44% retail investors. Blackrock is the largest institutional shareholder, holding 8.15% of ADMA shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.28% of its assets in ADMA Biologics shares.

ADMA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockADMA Biologics79.01%2.55%18.44%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock18.64M8.15%$208.45M
Vanguard group14.52M6.34%$162.30M
Invesco13.17M5.75%$147.25M
Nuveen asset management8.93M3.90%$99.78M
State street8.06M3.52%$90.11M
D. e. shaw6.82M2.98%$76.30M
American century companies6.05M2.65%$67.69M
Geode capital management5.24M2.29%$58.64M
Awm investment company5.10M2.23%$56.99M
Two sigma advisers, lp4.65M2.03%$52.04M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Stonepine capital management1.87M19.07%$20.91M
Awm investment company5.10M7.70%$56.99M
Altium capital management lp1.51M6.89%$16.88M
Ophir asset management pty1.83M3.63%$20.47M
Miura global management300.00K3.27%$3.35M
Mesirow institutional investment management1.76M1.72%$19.63M
Eam global investors660.99K1.66%$7.39M
Virtus investment advisers157.27K1.49%$1.76M
Oberweis asset management inc/2.04M1.40%$22.82M
Magnetar financial3.71M0.87%$41.50M

Top Buyers

HolderShares% AssetsChange
Invesco13.17M0.03%5.37M
Price t rowe associates inc /md/2.08M0.00%2.02M
Fmr1.88M0.00%1.87M
Vanguard group14.52M0.00%1.83M
Bank of montreal /can/1.60M0.01%1.60M

Top Sellers

HolderShares% AssetsChange
Perceptive advisors2.77M0.74%-3.66M
State street8.06M0.00%-2.49M
Ophir asset management pty1.83M3.63%-1.60M
Stonepine capital management1.87M19.07%-1.56M
Nuveen asset management8.93M0.03%-1.54M

New Positions

HolderShares% AssetsChangeValue
Bank of montreal /can/1.60M0.01%1.60M$17.89M
First trust advisors lp723.58K0.01%723.58K$8.09M
Healthcare of ontario pension plan trust fund578.50K0.02%578.50K$6.47M
Trexquant investment lp510.64K0.09%510.64K$5.71M
Segall bryant & hamill451.27K0.09%451.27K$5.05M

Sold Out

HolderChange
Ancora advisors-100.00
Abich financial wealth management-177.00
Innealta capital-213.00
Wr wealth planners-500.00
Old point trust & financial services n a-500.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202425517.51%180,834,8813.64%791.33%1497.97%8053.85%
Mar 31, 202421716.67%174,477,0703.15%771.37%13850.00%52-10.34%
Dec 31, 2023186-1.59%169,142,481-1.14%751.27%92-16.36%5826.09%
Sep 30, 20231895.00%171,085,6313.40%761.38%11025.00%46-24.59%
Jun 30, 20231809.76%165,456,8150.10%741.34%88-2.22%6152.50%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF14.85M6.28%13.26K
Vanguard Total Stock Mkt Idx Inv7.12M3.01%-33.04K
iShares Russell 2000 ETF5.80M2.45%-13.03K
SPDR® S&P Biotech ETF4.31M1.85%47.72K
Vanguard Institutional Extnd Mkt Idx Tr3.46M1.48%150.64K
Xtrackers MSCI World Swap ETF 1C3.15M1.33%-
CREF Stock R12.80M1.20%-102.61K
Invesco Small Cap Core2.73M1.17%-882.10K
Invesco Main Street Small Cap R62.73M1.17%-294.67K
American Century Small Cap Growth Inv2.53M1.09%-242.71K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 09, 2024Guiheen Lawrence P.-Sell$166.19K
Aug 30, 2024Kestenberg-Messina Kaitlin M. COO and SVP, ComplianceSell$408.05K
Aug 29, 2024Grossman Jerrold B-Sell$2.36M
Aug 26, 2024Grossman Adam S President and CEOSell$4.19M
Aug 27, 2024Grossman Adam S President and CEOSell$6.73M

Insider Transactions Trends


DateBuySell
2024 Q3-6
2024 Q2-1
2024 Q1-5
2023 Q4--
2023 Q326

ADMA Ownership FAQ


Who Owns ADMA Biologics?

ADMA Biologics shareholders are primarily institutional investors at 79.01%, followed by 2.55% insiders and 18.44% retail investors. The average institutional ownership in ADMA Biologics's industry, Biotech Stocks , is 44.97%, which ADMA Biologics exceeds.

Who owns the most shares of ADMA Biologics?

ADMA Biologics’s largest shareholders are Blackrock (18.64M shares, 8.15%), Vanguard group (14.52M shares, 6.34%), and Invesco (13.17M shares, 5.75%). Together, they hold 20.24% of ADMA Biologics’s total shares outstanding.

Does Blackrock own ADMA Biologics?

Yes, BlackRock owns 8.15% of ADMA Biologics, totaling 18.64M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 208.45M$. In the last quarter, BlackRock increased its holdings by 445.43K shares, a 2.45% change.

Who is ADMA Biologics’s biggest shareholder by percentage of total assets invested?

Stonepine capital management is ADMA Biologics’s biggest shareholder by percentage of total assets invested, with 19.07% of its assets in 1.87M ADMA Biologics shares, valued at 20.91M$.

Who is the top mutual fund holder of ADMA Biologics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of ADMA Biologics shares, with 6.28% of its total shares outstanding invested in 14.85M ADMA Biologics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools